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Objectives
To develop a model for determining the level of dose
adherence of Anti-Retroviral Therapy (ART) clients from
the first day of ART to the day of interview and to deter-
mine their level of dose adherence using the model.
Methods
A cross-sectional study was conducted using pre-tested
standardized questionnaires in exit-interviews in three
ART centres and eleven social support groups to deter-
mine the level of dose adherence of ART clients in the
Eastern Region of Ghana. A dose adherence computation
model was developed from the study based on the
observed doses, the expected doses, the missed doses and
the frequency at which clients defaulted since commence-
ment of ART. This model married the short-term recall of
missed doses and the long-term default frequency to
arrive at the observed/actual adherence levels of ART cli-
ents.
Results
The observed doses were derived from the difference
between the expected doses and the missed doses. Stand-
ard adherence levels derived from the model based on lit-
erature were 25%, 50%, 80% and 100%. However, 83.2%
of respondents were 100% adherent having honoured all
their re-fill appointments and never missing doses since
commencement of ART. 14% and 1.7% of the 725
respondents were 80% and 50% adherent respectively
whereas the remaining 1.1% were 25% adherent.
Observed adherence levels were statistically significant at
a p-value of 0.0517. Further analysis on factors affecting
dose adherence was conducted on the respondents
knowledge, attitudes and practices, socio-demographic
features, social support received, ARV dispensing consist-
ency and sources of ART information and there was no
significance over the adherence levels. Rather, the mecha-
nisms adopted for adherence significantly (p-value =
0.0517) affected adherence levels.
Conclusion
The Dose Adherence Computation Model complements
other methods for deducing patient's level of dose adher-
ence by considering the long-term default frequency in
addition to the short-term recall of missed doses.
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